Evidence map›Paper›PMID 29031713›Full record

ArticleMolecular metabolism2017

Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling.

Joseph Tam, Gergő Szanda, Adi Drori, Ziyi Liu, Resat Cinar, Yoshihiro Kashiwaya, Marc L Reitman, George Kunos

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Endocannabinoid System and Metabolism: The Influences of Sex.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Hypothalamic endocannabinoids in obesity: an old story with new challenges.Cellular and molecular life sciences : CMLS · 2021
    Review
  20. The Peripheral Cannabinoid Receptor Type 1 (CBMolecules (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Joseph TamObesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel. Electronic address: yossit@ekmd.huji.ac.il.
Gergő SzandaLaboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, USA.
Adi DroriObesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.
Ziyi LiuLaboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, USA.
Resat CinarLaboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, USA.
Yoshihiro KashiwayaLaboratory of Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, USA.
Marc L ReitmanDiabetes, Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
George KunosLaboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, USA. Electronic address: george.kunos@nih.gov.
National Institute on Alcohol Abuse and Alcoholism · USHebrew University of Jerusalem · ILNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn visceral obesity, an overactive endocannabinoid/CB

methodsWe analyzed the hypothalamic circuitry targeted by leptin following chronic treatment of DIO mice with JD5037.

resultsLeptin treatment or an increase in endogenous leptin following fasting/refeeding induced STAT3 phosphorylation in neurons in the arcuate nucleus (ARC) in lean and JD5037-treated DIO mice, but not in vehicle-treated DIO animals. Co-localization of pSTAT3 in leptin-treated mice was significantly less common with NPY

conclusionsPeripheral CB

Indexed as

AnimalsArcuate Nucleus of HypothalamusBody WeightCannabinoidsDietary FatsDiet, High-FatEatingHypothalamusLeptinMaleMiceMice, Inbred C57BLMice, ObeseNeuropeptide YObesityPro-OpiomelanocortinCannabinoidsCnr1 protein, ratDietary FatsJD5037LeptinMC4R protein, mouseNeuropeptide YPro-OpiomelanocortinPyrazolesReceptor, Cannabinoid, CB1Receptor, Melanocortin, Type 4Receptors, CannabinoidReceptors, LeptinSTAT3 Transcription FactorSulfonamidesDiet-induced obesityLeptin resistanceNPYPeripheral CB1 blockadePOMC

Identifiers

PMID29031713
PMCPMC5641628
OpenAlexW2718371109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.